GO
Loading...

Enter multiple symbols separated by commas

Baxter International Inc

More

  • June 26- Drug developer Celladon Corp said on Friday it may liquidate itself if it were unable to find a buyer, and was suspending development of its gene therapy for heart failure. Celladon said if it were to liquidate during the third quarter ending September, the net cash available for distribution to shareholders would be about $25 million- $30 million.

  • Eli Lilly and Cree are big market movers Thursday, 25 Jun 2015 | 4:46 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:. Eli Lilly and Co., up $2.54 to $84.80. Lindsay Corp., up $7.08 to $89.70.

  • NEW YORK— Baxalta Inc. will replace QEP Resources Inc. in the benchmark S&P 500 index, S&P Dow Jones Indices said. Baxalta, a biopharmaceutical company based in Deerfield, Illinois, will join the index after the close of trading June 30. Priceline Group Inc. will replace Baxter International Inc. in the S&P 100. Baxter, which is spinning off Baxalta later this...

  • Biotech's boom fuels real estate here Thursday, 30 Apr 2015 | 12:11 PM ET
    Signage sits on display in an atrium at Genzyme Corp.'s headquarters in Cambridge, Massachusetts.

    As biotech has boomed over the last few years, so has real estate in Kendall Square in Cambridge, Massachusetts.

  • Charts say market headed lower. What to sell Monday, 6 Apr 2015 | 11:02 AM ET
    NYSE New York Stock Exchange traders markets

    Technical analysts, those who study charts to make buying and selling decisions, believe a bigger pullback could begin this week.

  • Pete Najarian buys Apple ahead of Watch release Tuesday, 31 Mar 2015 | 12:52 PM ET
    Tim Cook introduces the Apple Watch

    Pete Najarian bought shares of Apple for his Halftime Report Portfolio on the belief that the Apple Watch and new iPhones this year will drive the shares higher.

  • LONDON, March 12- Pfizer is seeking new vaccine opportunities across the age spectrum as it broadens its portfolio by delivering shots into the arms of adolescents and the elderly, as well as infants. For many years the vaccines industry has been dominated by five big companies, but that has shrunk to four with GlaxoSmithKline's purchase of Novartis' business.

  • March 9- CTI BioPharma Corp's experimental blood cancer drug achieved the main goal of a late-stage study, but at least two analysts said the pill would not directly compete with Incyte Corp's treatment. "...we could see pacritinib ultimately finding a niche in the market among low platelet patients and perhaps taking incremental share away from Incyte," Wells...

  • March 9- CTI BioPharma Corp said its experimental blood cancer treatment achieved the main goal of a late-stage study, sending its shares up 24 percent in premarket trading. CTI BioPharma said nearly 18,000 patients are estimated to live with myelofibrosis in the United States. Pacritinib, one of four cancer compounds CTI BioPharma is developing, is a...

  • Lightning Round: This stock needs to split up Tuesday, 10 Feb 2015 | 7:31 PM ET
    Mad Money Lightning Round

    Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Cramer Remix: You need to see this Apple news Tuesday, 10 Feb 2015 | 7:11 PM ET
    Jim Cramer on the set of Mad Money

    Apple made news after the close and “Mad Money’s” Jim Cramer is clueing you in.

  • Fastest trader picking the slowest stocks in ’15 Monday, 5 Jan 2015 | 5:30 AM ET
    A UPS worker delivers packages in Chicago, Dec. 26, 2013.

    Pete Najarian buying UPS, blue chips

  • Lightning Round: Time to pull the trigger Wednesday, 5 Nov 2014 | 7:39 PM ET
    Mad Money Lightning Round

    Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.

  • What to buy now on the Republican takeover Wednesday, 5 Nov 2014 | 12:23 PM ET

    Investors say shares of coal and natural gas companies, and medical device makers, have not yet fully priced in the Republican blowout in the election.

  • Here's where to put your money to work, pros say Thursday, 23 Oct 2014 | 4:04 PM ET
    Traders work on the floor of the New York Stock Exchange.

    As stocks rallied Thursday on positive earnings news, market pros looked at names they'd put on their shopping lists.

  • Early movers: GS, DAL, MAT, AXP, NFLX & more Thursday, 16 Oct 2014 | 8:21 AM ET
    Alibaba IPO NYSE

    Some of the names on the move ahead of the open.

  • Stock rally halts 3-day rout for S&P 500, Nasdaq Wednesday, 24 Sep 2014 | 4:37 PM ET

    Stocks rose on Wednesday, with the S&P 500 rebounding from a five-week low, aftera report on new-home sales.

  • Early movers: SBUX, BBRY, WAG, WMT, ATVI & more Wednesday, 24 Sep 2014 | 7:34 AM ET
    Trader on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Midday movers: Bank of America, eBay, 58.com & more Thursday, 21 Aug 2014 | 1:34 PM ET

    Some of Thursday's midday movers:

  • US labs on standby to start work on Ebola drug Sunday, 10 Aug 2014 | 6:02 AM ET
    A nurse wears protective clothing as he demonstrates the facilities in place at the Royal Free Hospital in north London on August 6, 2014, in preparation for a patient testing positive for the Ebola virus.

    All three U.S. laboratories established to fight major public health threats say they are standing by to scale up a treatment for Ebola.